“…Today, the increasing number of global mortality and morbidity due to parasitic infections such as Malaria , Visceral leishmaniasis , African trypanosomiasis , Trichomoniasis , and other parasitic diseases has caused much concern at the global level (Date, Joshi, & Patravale, 2007). In recent years, studies have shown that Cur nanoparticles have a special role in the treatment of parasitic infections (Busari et al, 2017; Chaubey et al, 2018; dos Santos et al, 2020; Ghosh, Banerjee, Bhandary, & Surolia, 2014; Memvanga, Coco, & Préat, 2013. In an in vivo study, Mokbel, Baiuomy, Sabry, Mohammed, and El‐Dardiry (2020) designed nanoformulations containing Cur‐gold‐praziquantel and tested its antiparasitic activity against parasite infection with Schistosoma mansoni in the C57BL/6 mice model.…”